PR Newswire
BUENA, N.J., March 22, 2017
BUENA, N.J., March 22, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the Oppenheimer 27th Annual Healthcare Conference. The Conference is taking place on March 21-22, 2017 at the Westin New York Grand Central, New York, NY.
Jason Grenfell-Gardner, President and CEO of Teligent, Inc. will present on Wednesday, March 22, 2017 at 1:00 p.m. ET.
The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com. A replay will be available for 30 days.
About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company. Our mission is to be a leading player in the specialty generic prescription drug market. Learn more on our website www.teligent.com.
Contact: |
Jenniffer Collins |
Teligent, Inc. | |
(856) 697-4379 | |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/teligent-inc-to-present-at-oppenheimer-27th-annual-healthcare-conference-on-march-22-2017-300427235.html
SOURCE Teligent, Inc.
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member